Hanseatic Management Services Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hanseatic Management Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$12.94 - $19.2 $647 - $960	50 New	50 $6,000
Q2 2022 Aug 05, 2022	SELL	$83.14 - $145.99 $4,157 - $7,299	-50 Closed	0 $0
Q3 2021 Oct 05, 2021	BUY	$98.85 - $138.91 $4,942 - $6,945	50 New	50 $7,000
Q3 2019 Oct 31, 2019	SELL	$37.38 - $49.47 $1,794 - $2,374	-48 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$39.79 - $67.01 $1,909 - $3,216	48 New	48 $2,000
Q1 2019 May 08, 2019	SELL	$34.52 - $53.29 $1,415 - $2,184	-41 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $1,344 - $1,763	41 New	41 $2,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.